5-HT1A receptor-mediated autoinhibition does not function at physiological firing rates:: evidence from in vitro electrophysiological studies in the rat dorsal raphe nucleus

被引:36
作者
Johnson, DA [1 ]
Gartside, SE [1 ]
Ingram, CD [1 ]
机构
[1] Univ Newcastle Upon Tyne, Sch Med, Sch Neurosci & Psychiat, Psychobiol Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England
关键词
serotonin (5-HT); dorsal raphe nucleus (DRN); fluoxetine; autoinhibition; 5-HT reuptake; 5-HT1A receptor;
D O I
10.1016/S0028-3908(02)00116-8
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
5-HT1A-mediated autoinhibition of neurones in the dorsal raphe nucleus (DRN) is considered to be the principal inhibitory regulator of 5-HT neuronal activity. The activation of this receptor by endogenous 5-HT was investigated using electrophysiological recordings from the rat DRN in vitro. At a concentration which blocked the inhibitory effect of exogenous 5-HT, the 5-HT1A antagonist WAY 100635 did not alter basal firing rate or modulate the excitatory response to the alpha(1)-agonist phenylephrine. Blockade of 5-HT reuptake by a concentration of fluoxetine, which enhanced the inhibitory effect of exogenous 5-HT, lowered phenylephrine-induced basal firing presumably due to potentiation of the effect of endogenous 5-HT. However, this effect was not firing rate dependent and neither the proportional increase nor the time-course of the response to a higher concentration of phenylephrine were altered in the presence of fluoxetine. These data suggest that the inhibitory 5-HT1A receptor on raphe neurones is neither tonically activated nor plays any role in modulating the response to excitatory transmitters. Thus, at physiological firing rates this receptor does not appear to function as an autoreceptor of serotonergic neurones of the DRN. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:959 / 965
页数:7
相关论文
共 29 条
[1]   Regulation of the release of 5-hydroxytryptamine in the median raphe nucleus of the rat by catecholaminergic afferents [J].
Adell, A ;
Artigas, F .
EUROPEAN JOURNAL OF NEUROSCIENCE, 1999, 11 (07) :2305-2311
[2]   INVIVO BRAIN DIALYSIS STUDY OF THE SOMATODENDRITIC RELEASE OF SEROTONIN IN THE RAPHE NUCLEI OF THE RAT - EFFECTS OF 8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN [J].
ADELL, A ;
CARCELLER, A ;
ARTIGAS, F .
JOURNAL OF NEUROCHEMISTRY, 1993, 60 (05) :1673-1681
[3]   THE 5-HT1A RECEPTOR ANTAGONIST (S)-UH-301 BLOCKS THE (R)-8-OH-DPAT-INDUCED INHIBITION OF SEROTONERGIC DORSAL RAPHE CELL FIRING IN THE RAT [J].
ARBORELIUS, L ;
HOOK, BB ;
HACKSELL, U ;
SVENSSON, TH .
JOURNAL OF NEURAL TRANSMISSION-GENERAL SECTION, 1994, 96 (03) :179-186
[4]  
BARABAN JM, 1980, NEUROPHARMACOLOGY, V19, P335
[5]   A review of central 5-HT receptors and their function [J].
Barnes, NM ;
Sharp, T .
NEUROPHARMACOLOGY, 1999, 38 (08) :1083-1152
[6]   MODIFICATION OF 5-HT NEURON PROPERTIES BY SUSTAINED ADMINISTRATION OF THE 5-HT1A AGONIST GEPIRONE - ELECTROPHYSIOLOGICAL STUDIES IN THE RAT-BRAIN [J].
BLIER, P ;
DEMONTIGNY, C .
SYNAPSE, 1987, 1 (05) :470-480
[7]  
BOSKER F, 1994, J NEUROCHEM, V63, P2165
[8]  
Corradetti R, 1996, J PHARMACOL EXP THER, V278, P679
[9]   Antagonist properties of (-)-pindolol and WAY 100635 at somatodendritic and postsynaptic 5-HT1A receptors in the rat brain [J].
Corradetti, R ;
Laaris, N ;
Hanoun, N ;
Laporte, AM ;
Le Poul, E ;
Hamon, M ;
Lanfumey, L .
BRITISH JOURNAL OF PHARMACOLOGY, 1998, 123 (03) :449-462
[10]   EVIDENCE THAT 5-HYDROXYTRYPTAMINE RELEASE IN RAT DORSAL RAPHE NUCLEUS IS CONTROLLED BY 5-HT1A, 5-HT1B AND 5-HT1D AUTORECEPTORS [J].
DAVIDSON, C ;
STAMFORD, JA .
BRITISH JOURNAL OF PHARMACOLOGY, 1995, 114 (06) :1107-1109